Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 vs Docetaxel or Irinotecan in Advanced Gastric Cancer
NCT01084330Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of Luminespib in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Novartis. Started Apr 2010; status: completed.
02
Drugs
Luminespib
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT01084330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084330.